Adicet Bio, Inc. (ACET)
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting.
ADMA Biologics, Inc. (ADMA)
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
Rhythm Pharmaceuticals, Inc. (RYTM)
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company’s lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC).
“I Don’t Care If The Market Is Crashing, Rebounding... Or Just Going Sideways…”
Here’s How To Potentially Retire In 18 Months With $2.4 Million Regardless Of Market Conditions. It takes a certain sort of person to sit back while the global markets are on fire and say, ‘I just don’t care…bring it on. What do they know that you don’t? (ad)
Find Out
Limited Time Discount
Upgrade To TradersPro Premier Suite
Don't let costly emotions keep you from holding losers too long and selling winners too soon. Introducing an exclusive, algorithm-driven signal software that delivers only the best stocks to you daily and keeps you in profitable trades longer.
